Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple body wrap calm severe autism outbursts?

NCT ID NCT03164746

Symptom relief Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether wrapping children with autism in sheets (wet or dry) can reduce severe injurious behaviors like self-harm or aggression. 48 children took part, and researchers compared wet wraps to dry wraps. The goal was to see if this gentle, drug-free approach could help when other treatments haven't worked.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
therapeutic body wraps (wet or dry sheets)
What this could lead to
If effective, this could offer a non-drug option to help calm severe behavioral outbursts in children with autism.
What could go wrong
This is a small, early-stage trial with only 48 participants. The results may not apply to all children, and the effect may be small or no better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

48 people

The number who actually took part.

Start date

Dec 2007

Finished

Dec 2014

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * a current diagnosis of autism, Asperger syndrome, atypical autism according ICD-10 criteria confirmed by specialized clinical assessment; * presenting severe behavioural disturbances such as hetero and self-injurious behaviours, automutilation, severe motor hyperactivity, severe stereotypies. * having a systematically consultation by a neuro pediatric. Exclusion Criteria: * children with known organic syndrome and/or non-stabilized neuropediatric (e.g. seizures) or medical (e.g. diabetes mellitus) comorbidities. * patients with stabilized seizure condition, antiepileptic medication should be stable for at least 4 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Autism spectrum disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

autism autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Autism spectrum disorder

Contacts and locations

Locations

  • Centre Hospitalier Montfavet

    Avignon, France

  • Centre Hospitalier Robert Ballanger

    Aulnay-sous-Bois, France

  • Centre Hospitalier d'Arras

    Arras, France

  • Centre Hospitalier de Douai

    Douai, France

  • Centre Hospitalier de Lens

    Lens, France

  • Centre de Santé Mentale Angevin

    Angers, France

  • Etablissement Public de Santé Mentale Val de Lys-Artois

    Saint-Venant, France

  • Etablissement Public de Santé Roger Prévot

    Gennevilliers, France

  • Etablissement de Santé Maison Blanche

    Paris, France

  • Groupe Hospitalier Pitier-Salpêtrière

    Paris, France

  • Hôpital Fontan, CHRU

    Lille, France

  • Institut Départemental Albert Calmette

    Camiers, France

  • Institut Médico-éducatif

    Montigny-en-Ostrevent, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.